Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer
NCT01469598Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Aug 2011
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, docetaxel in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Samsung Medical Center. Started Aug 2011; status: completed.
02
Drugs
gemcitabinedocetaxel
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT01469598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01469598.